BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grim SA, Reid GE, Clark NM. Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients. Expert Opin Pharmacother 2017;18:767-79. [PMID: 28425766 DOI: 10.1080/14656566.2017.1322063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Chiamenti L, Silva FPD, Schallemberger K, Demoliner M, Rigotto C, Fleck JD. Cytotoxicity and antiviral activity evaluation of Cymbopogon spp hydroethanolic extracts. Braz J Pharm Sci 2019;55:e18063. [DOI: 10.1590/s2175-97902019000118063] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Peghin M, Los-Arcos I, Hirsch HH, Codina G, Monforte V, Bravo C, Berastegui C, Jauregui A, Romero L, Cabral E, Ferrer R, Sacanell J, Román A, Len O, Gavaldà J. Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction. Clin Infect Dis 2019;69:1192-7. [PMID: 30561555 DOI: 10.1093/cid/ciy1047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
3 Lynch JP 3rd, Kajon AE. Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment. Semin Respir Crit Care Med 2021;42:800-21. [PMID: 34918322 DOI: 10.1055/s-0041-1733802] [Reference Citation Analysis]
4 Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients. Intensive Care Med 2019;45:573-91. [PMID: 30911807 DOI: 10.1007/s00134-019-05597-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
5 Lee KH, Yoo SG, Cho Y, Kwon DE, La Y, Han SH, Kim MS, Choi JS, Kim SI, Kim YS, Min YH, Cheong JW, Kim JS, Song YG. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients. J Microbiol Immunol Infect 2021;54:253-60. [PMID: 31262511 DOI: 10.1016/j.jmii.2019.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kong D, Li M, Gong W. SARS-Cov-2 infection in transplant-related biology: Where do we stand? Ann Transplant 2020;25:e924768. [PMID: 33372171 DOI: 10.12659/AOT.924768] [Reference Citation Analysis]
7 Liu M, Jiang L, Cao W, Wu J, Chen X. Identification of Inhibitors and Drug Targets for Human Adenovirus Infections. Viruses 2022;14:959. [DOI: 10.3390/v14050959] [Reference Citation Analysis]
8 Lejeune S, Deschildre A, Le Rouzic O, Engelmann I, Dessein R, Pichavant M, Gosset P. Childhood asthma heterogeneity at the era of precision medicine: Modulating the immune response or the microbiota for the management of asthma attack. Biochem Pharmacol 2020;179:114046. [PMID: 32446884 DOI: 10.1016/j.bcp.2020.114046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Reckziegel M, Weber-Osel C, Egerer R, Gruhn B, Kubek F, Walther M, Wilhelm S, Zell R, Krumbholz A. Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection. Eur J Clin Microbiol Infect Dis 2020;39:1581-92. [PMID: 32462500 DOI: 10.1007/s10096-020-03878-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Casanova V, Sousa FH, Stevens C, Barlow PG. Antiviral therapeutic approaches for human rhinovirus infections. Future Virol 2018;13:505-18. [PMID: 30245735 DOI: 10.2217/fvl-2018-0016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]